Works matching IS 16197070 AND DT 2025 AND VI 52 AND IP 6

Results: 34

Abdelhamid H. Elgazzar. Orthopedic Nuclear Medicine, 3rd edition. Springer Nature Switzerland AG 2024, ISBN 978-3-031-51931-4.

Published in:

2025

By:

Mansi, Luigi

Publication type:

Book Review

Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2051, doi. 10.1007/s00259-025-07089-2

By:

Li, Yujia;
Yang, Jinhui;
Xiao, Ling;
Zhou, Ming;
Li, Jian;
Cai, Yi;
Gao, Xiaomei;
Rominger, Axel;
Shi, Kuangyu;
Seifert, Robert;
Su, Qi;
Tang, Yongxiang;
Hu, Shuo

Publication type:

Article

Beyond FAP: ANTXR1 as a novel target for PET imaging and radio-ligand therapy in immuno-oncology?

Published in:

2025

By:

Seban, Romain-David;
Buvat, Irene;
Champion, Laurence;
Bidard, Francois-Clement;
Kieffer, Yann;
Vincent-Salomon, Anne;
Peltier, Agathe;
Mechta-Grigoriou, Fatima

Publication type:

Letter

GLUT1 as a generic biomarker enables near-infrared fluorescence molecular imaging guided precise intraoperative tumor detection in breast cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2171, doi. 10.1007/s00259-025-07095-4

By:

Qiu, Si-Qi;
He, Xiao-Feng;
Liang, Xiao-Long;
Shi, Guang-Yuan;
Zhao, Meng-Long;
Li, Fan;
Wu, Zhi-Yong;
Tian, Jie;
Zhai, Tian-Tian;
Du, Yang

Publication type:

Article

[18F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2076, doi. 10.1007/s00259-025-07085-6

By:

Bauckneht, Matteo;
Pasini, Giovanni;
Di Raimondo, Tania;
Russo, Giorgio;
Raffa, Stefano;
Donegani, Maria Isabella;
Dubois, Daniela;
Peñuela, Leonardo;
Sofia, Luca;
Celesti, Greta;
Bini, Fabiano;
Marinozzi, Franco;
Lanfranchi, Francesco;
Laudicella, Riccardo;
Sambuceti, Gianmario;
Stefano, Alessandro

Publication type:

Article

Exploring the role of multimodal [18F]F-PSMA-1007 PET/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2087, doi. 10.1007/s00259-025-07099-0

By:

Miao, Cunke;
Yao, Fei;
Fang, Junfei;
Tong, Yingnuo;
Lin, Heng;
Lu, Chuntao;
Peng, Lu;
Zhong, JiaQi;
Lin, Yezhi

Publication type:

Article

[68Ga]Ga‑FAPI PET/CT in the evaluation of Langerhans cell histiocytosis: comparison with [18F]FDG PET/CT.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2187, doi. 10.1007/s00259-025-07097-2

By:

Zhang, Wenjie;
Wu, Yu;
Guo, Linlin;
Li, Xin;
Shen, Guohua

Publication type:

Article

Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2015, doi. 10.1007/s00259-025-07076-7

By:

Wenzel, Mike;
Hoeh, Benedikt;
Siech, Carolin;
Koll, Florestan;
Humke, Clara;
Groener, Daniel;
Steuber, Thomas;
Graefen, Markus;
Maurer, Tobias;
Banek, Severine;
Chun, Felix K. H.;
Mandel, Philipp

Publication type:

Article

Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson's disease.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2002, doi. 10.1007/s00259-025-07070-z

By:

Silva-Rodríguez, Jesús;
Labrador-Espinosa, Miguel Ángel;
Castro-Labrador, Sandra;
Muñoz-Delgado, Laura;
Franco-Rosado, Pablo;
Castellano-Guerrero, Ana María;
Macías-García, Daniel;
Jesús, Silvia;
Adarmes-Gómez, Astrid D.;
Carrillo, Fátima;
Martín-Rodríguez, Juan Francisco;
García-Solís, David;
Roldán-Lora, Florinda;
Mir, Pablo;
Grothe, Michel J.

Publication type:

Article

Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2157, doi. 10.1007/s00259-025-07093-6

By:

Lin, En;
Song, Miaomiao;
Wang, Bo;
Shi, Xiaojing;
Zhao, Jiali;
Fu, Lidan;
Bai, Zirui;
Zou, Baojia;
Zeng, Guifang;
Zhuo, Wenfeng;
Li, Peiping;
Cai, Chaonong;
Cheng, Zhen;
Hu, Zhenhua;
Li, Jian

Publication type:

Article

Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2118, doi. 10.1007/s00259-025-07084-7

By:

Zhang, Yafei;
Xu, Mimi;
Wang, Yu;
Yu, Fang;
Chen, Xinxin;
Wang, Guangfa;
Zhao, Kui;
Yang, Hong;
Su, Xinhui

Publication type:

Article

First real-world clinical experience with [177Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2034, doi. 10.1007/s00259-025-07082-9

By:

Ling, Sui wai;
de Lussanet de la Sablonière, Quido;
Ananta, Michael;
de Blois, Erik;
Koolen, Stijn L. W.;
Drexhage, Roosmarijn C.;
Hofland, Johannes;
Robbrecht, Debbie G. J.;
van der Veldt, Astrid A M;
Verburg, Frederik A;
Brabander, Tessa

Publication type:

Article

Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [68Ga]Ga-PSMA-11 and [18F]PSMA-1007.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2023, doi. 10.1007/s00259-025-07078-5

By:

Waibel, Philipp Moritz Adrian;
Glavynskyi, Ievgen;
Fechter, Tobias;
Mix, Michael;
Kind, Felix;
Sigle, August;
Jilg, Cordula Annette;
Gratzke, Christian;
Werner, Martin;
Schilling, Oliver;
Bronsert, Peter;
Freitag, Martin Thomas;
Zamboglou, Constantinos;
Grosu, Anca-Ligia;
Spohn, Simon Konrad Benedikt

Publication type:

Article

Influence of diabetes mellitus on metabolic networks in lung cancer patients: an analysis using dynamic total-body PET/CT imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2145, doi. 10.1007/s00259-025-07081-w

By:

Sun, Lubing;
Wu, Yaping;
Sun, Tao;
Li, Panlong;
Liang, Junting;
Yu, Xuan;
Yang, Junpeng;
Meng, Nan;
Wang, Meiyun;
Chen, Chuanliang

Publication type:

Article

Trends in nanobody radiotheranostics.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2225, doi. 10.1007/s00259-025-07077-6

By:

Long, Xingru;
Cheng, Sixuan;
Lan, Xiaoli;
Wei, Weijun;
Jiang, Dawei

Publication type:

Article

The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2198, doi. 10.1007/s00259-025-07071-y

By:

Liu, Luoxia;
Shi, Yifan;
He, Shujie;
Yang, Jingfei;
Song, Shuang;
Wang, Dongdong;
Wang, Ziqiang;
Zhou, Huimin;
Deng, Xiaoyun;
Zou, Sijuan;
Zhu, Yuankai;
Yu, Bo;
Zhu, Xiaohua

Publication type:

Article

PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2212, doi. 10.1007/s00259-025-07069-6

By:

Zhang, Jucheng;
Zhang, Xiaohui;
Zhong, Yan;
Wang, Jing;
Zhong, Chao;
Xiao, Meiling;
Chen, Yuhan;
Zhang, Hong

Publication type:

Article

The true negative [⁶⁸Ga]Ga-Trivehexin PET/CT in Solid Pseudopapillary Neoplasm of pancreas, mimicking pancreatic adenocarcinoma in [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI scans.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1942, doi. 10.1007/s00259-024-06972-8

By:

Novruzov, Fuad;
Mehdi, Elnur;
Aliyeva, Narmin;
Orucova, Parvin;
Simecek, Jakub;
Aliyev, Jamil

Publication type:

Article

PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2063, doi. 10.1007/s00259-024-07065-2

By:

Ma, Qiaoke;
Chen, Bei;
Seifert, Robert;
Zhou, Rui;
Xiao, Ling;
Yang, Jinhui;
Rominger, Axel;
Shi, Kuangyu;
Li, Weikai;
Tang, Yongxiang;
Hu, Shuo

Publication type:

Article

Early-phase 18F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer's disease: a comparison with 18F-FDG-PET and early-phase amyloid-PET.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1958, doi. 10.1007/s00259-024-07063-4

By:

Boccalini, Cecilia;
Peretti, Debora Elisa;
Mathoux, Gregory;
Iaccarino, Leonardo;
Ribaldi, Federica;
Scheffler, Max;
Perani, Daniela;
Frisoni, Giovanni B.;
Garibotto, Valentina

Publication type:

Article

[18F]RCCB6 immunoPET/CT detects primary clear cell renal cell carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1944, doi. 10.1007/s00259-024-07001-4

By:

Wu, Shuo;
Wu, Qianyun;
Liu, Jianjun;
Zhang, Jin;
Wei, Weijun

Publication type:

Article

Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1939, doi. 10.1007/s00259-024-06998-y

By:

Holzgreve, Adrien;
Harter, Patrick N.;
Forbrig, Robert;
Quach, Stefanie;
Thon, Niklas;
Schichor, Christian;
Tonn, Joerg-Christian;
Niyazi, Maximilian;
Brendel, Matthias;
von Baumgarten, Louisa;
Albert, Nathalie L.

Publication type:

Article

Assessment of viable tumours by [68Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2132, doi. 10.1007/s00259-024-07062-5

By:

Zhu, Dongling;
Song, Shuang;
Zou, Sijuan;
Kuang, Dong;
Wang, Dongdong;
Min, Xiangde;
Feng, Zhaoyan;
Zhu, Yuankai;
Cheng, Zhaoting;
Cheng, Siyuan;
Zhou, Jianyuan;
Pan, Ruping;
Chen, Haojun;
Zhu, Xiaohua

Publication type:

Article

Correction to: Preclinical evaluation of 64Cu/177Lu‑labelled anti‑CD30 monoclonal antibody for theranostics in CD30‑positive lymphoma.

Published in:

2025

By:

Yang, Xu;
Liu, Jun;
Li, Cuicui;
Zheng, Lingling;
Lu, Xia;
Zhou, Ziang;
Zhu, Xianyu;
Gong, Jianhua;
Miao, Qingfang;
Yang, Jigang

Publication type:

Correction Notice

Predictive and prognostic value of 18F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2096, doi. 10.1007/s00259-024-07058-1

By:

Jeong, Hyehyun;
Ryu, Jeongryul;
Jeong, Jae Ho;
Han, Sangwon;
Hyung, Jaewon;
Ahn, Jin-Hee;
Jung, Kyung Hae;
Kim, Sung-Bae;
Jeong, Byung-Kwan;
Lee, Hee Jin;
Gong, Gyungyub;
Moon, Dae Hyuk

Publication type:

Article

Letter to the editor about 360 CZT bone imaging.

Published in:

2025

By:

Graham, Richard;
Van Den Wyngaert, Tim

Publication type:

Letter

An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2107, doi. 10.1007/s00259-024-07056-3

By:

Suzuki, Hiroyuki;
Yamashita, Saki;
Tanaka, Shoko;
Kannaka, Kento;
Sasaki, Ichiro;
Ohshima, Yasuhiro;
Watanabe, Shigeki;
Ooe, Kazuhiro;
Watabe, Tadashi;
Ishioka, Noriko S.;
Tanaka, Hiroshi;
Uehara, Tomoya

Publication type:

Article

Transcriptionally downregulated GABAergic genes associated with synaptic density network dysfunction in temporal lobe epilepsy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1970, doi. 10.1007/s00259-024-07054-5

By:

Li, Rong;
Xiao, Ling;
Han, Honghao;
Long, Hongyu;
Liao, Wei;
Yang, Zhenzhe;
Zhu, Haoyue;
Wang, Xuyang;
Zou, Ting;
Huang, Yongwen;
Biswal, Bharat B.;
Zhou, Ming;
Li, Jian;
Li, Yulai;
Rominger, Axel;
Shi, Kuangyu;
Chen, Huafu;
Tang, Yongxiang;
Feng, Li;
Hu, Shuo

Publication type:

Article

Clinical impact of an explainable machine learning with amino acid PET imaging: application to the diagnosis of aggressive glioma.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1989, doi. 10.1007/s00259-024-07053-6

By:

Ahrari, Shamimeh;
Zaragori, Timothée;
Zinsz, Adeline;
Hossu, Gabriela;
Oster, Julien;
Allard, Bastien;
Al Mansour, Laure;
Bessac, Darejan;
Boumedine, Sami;
Bund, Caroline;
De Leiris, Nicolas;
Flaus, Anthime;
Guedj, Eric;
Kas, Aurélie;
Keromnes, Nathalie;
Kiraz, Kevin;
Kuijper, Fiene Marie;
Maitre, Valentine;
Querellou, Solène;
Stien, Guilhem

Publication type:

Article

Correction to: Feasibility of PET‑enabled dual‑energy CT imaging: First physical phantom and initial patient study results.

Published in:

2025

By:

Zhu, Yansong;
Li, Siqi;
Xie, Zhaoheng;
Leung, Edwin K.;
Bayerlein, Reimund;
Omidvari, Negar;
Abdelhafez, Yasser G.;
Cherry, Simon R.;
Qi, Jinyi;
Badawi, Ramsey D.;
Spencer, Benjamin A.;
Wang, Guobao

Publication type:

Correction Notice

Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1955, doi. 10.1007/s00259-024-07047-4

By:

Van Leeuwen, Fijs W.B.;
Pouget, Jean-Pierre;
Lassmann, Michael

Publication type:

Article

Moganshan international consensus on further strengthening global scientific collaboration in the field of molecular imaging.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1951, doi. 10.1007/s00259-024-07040-x

By:

Tian, Mei;
Chai, Zhifang;
Chen, Lin;
Chiti, Arturo;
Civelek, Cahid A.;
Endo, Keigo;
Gary, Ulaner;
Jin, Li;
Manning, Charles;
Murakami, Koji;
Schelbert, Heinrich;
Schwaiger, Markus;
Tamaki, Nagara;
Tan, Weihong;
Watanabe, Yasuyoshi;
Yun, Mijin;
Zhang, Hong

Publication type:

Article

Prognostic 18F-flotufolastat PET parameters for outcome assessment of 177Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 2041, doi. 10.1007/s00259-024-07003-2

By:

Karimzadeh, Amir;
Hansen, Kimberley;
Hasa, Ergela;
Haller, Bernhard;
Heck, Matthias M.;
Tauber, Robert;
D'Alessandria, Calogero;
Weber, Wolfgang A.;
Eiber, Matthias;
Rauscher, Isabel

Publication type:

Article

Bilateral intense [68 Ga]Ga-PSMA‑11 uptake in cyproterone acetate induced gynecomastia.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2025, v. 52, n. 6, p. 1937, doi. 10.1007/s00259-024-06960-y

By:

Bodart, Fiona;
Gheysens, Olivier;
Seront, Emmanuel;
Van Damme, Julien;
Jamar, François

Publication type:

Article

Works matching IS 16197070 AND DT 2025 AND VI 52 AND IP 6

Abdelhamid H. Elgazzar. Orthopedic Nuclear Medicine, 3rd edition. Springer Nature Switzerland AG 2024, ISBN 978-3-031-51931-4.

Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy.

Beyond FAP: ANTXR1 as a novel target for PET imaging and radio-ligand therapy in immuno-oncology?

GLUT1 as a generic biomarker enables near-infrared fluorescence molecular imaging guided precise intraoperative tumor detection in breast cancer.

[<sup>18</sup>F]PSMA-1007 PET/CT-based radiomics may help enhance the interpretation of bone focal uptakes in hormone-sensitive prostate cancer patients.

Exploring the role of multimodal [<sup>18</sup>F]F-PSMA-1007 PET/CT and multiparametric MRI data in predicting ISUP grading of primary prostate cancer.

[<sup>68</sup>Ga]Ga‑FAPI PET/CT in the evaluation of Langerhans cell histiocytosis: comparison with [<sup>18</sup>F]FDG PET/CT.

Lutetium-177 PSMA radioligand therapy in taxan-naive first- and second-line metastatic castration resistant prostate cancer after first-line ARPI therapy.

Imaging biomarkers of cortical neurodegeneration underlying cognitive impairment in Parkinson's disease.

Fibroblast activation protein peptide-targeted NIR-I/II fluorescence imaging for stable and functional detection of hepatocellular carcinoma.

Value of [<sup>18</sup>F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy.

First real-world clinical experience with [<sup>177</sup>Lu]Lu-PSMA-I&T in patients with metastatic castration-resistant prostate cancer beyond VISION and TheraP criteria.

Can PSMA PET detect intratumour heterogeneity in histological PSMA expression of primary prostate cancer? Analysis of [<sup>68</sup>Ga]Ga-PSMA-11 and [<sup>18</sup>F]PSMA-1007.

Influence of diabetes mellitus on metabolic networks in lung cancer patients: an analysis using dynamic total-body PET/CT imaging.

Trends in nanobody radiotheranostics.

The molar dose of FAPI administered impacts on the FAP-targeted PET imaging and therapy in mouse syngeneic tumor models.

PET radiomics for histologic subtype classification of non-small cell lung cancer: a systematic review and meta-analysis.

The true negative [⁶⁸Ga]Ga-Trivehexin PET/CT in Solid Pseudopapillary Neoplasm of pancreas, mimicking pancreatic adenocarcinoma in [¹⁸F]FDG and [⁶⁸Ga]Ga-FAPI scans.

PSMA PET/CT based multimodal deep learning model for accurate prediction of pelvic lymph-node metastases in prostate cancer patients identified as candidates for extended pelvic lymph node dissection by preoperative nomograms.

Early-phase <sup>18</sup>F-Flortaucipir tau-PET as a proxy of brain metabolism in Alzheimer's disease: a comparison with <sup>18</sup>F-FDG-PET and early-phase amyloid-PET.

[<sup>18</sup>F]RCCB6 immunoPET/CT detects primary clear cell renal cell carcinoma.

Flip-flop phenomenon on dual SSTR PET and amino acid PET in a case of recurrent meningioma with malignant transformation.

Assessment of viable tumours by [<sup>68</sup>Ga]Ga-FAPI-04 PET/CT after local regional treatment in patients with hepatocellular carcinoma.

Correction to: Preclinical evaluation of 64Cu/177Lu‑labelled anti‑CD30 monoclonal antibody for theranostics in CD30‑positive lymphoma.

Predictive and prognostic value of <sup>18</sup>F-FES PET/CT for patients with recurrent or metastatic breast cancer treated with endocrine therapy plus cyclin-dependent kinase 4/6 inhibitors.

Letter to the editor about 360 CZT bone imaging.

An <sup>211</sup>At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma.

Transcriptionally downregulated GABAergic genes associated with synaptic density network dysfunction in temporal lobe epilepsy.

Clinical impact of an explainable machine learning with amino acid PET imaging: application to the diagnosis of aggressive glioma.

Correction to: Feasibility of PET‑enabled dual‑energy CT imaging: First physical phantom and initial patient study results.

Optical (Cherenkov) dosimetry to unravel the radiobiological effects of radioisotope based therapy.

Moganshan international consensus on further strengthening global scientific collaboration in the field of molecular imaging.

Prognostic <sup>18</sup>F-flotufolastat PET parameters for outcome assessment of <sup>177</sup>Lu-labeled PSMA-targeted radioligand therapy in metastatic castration-resistant prostate cancer.

Bilateral intense [68 Ga]Ga-PSMA‑11 uptake in cyproterone acetate induced gynecomastia.